Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open Access
- 4 March 2010
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 362 (9), 779-789
- https://doi.org/10.1056/nejmoa0907118
Abstract
Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other.Keywords
This publication has 26 references indexed in Scilit:
- Dopamine therapy in septic shock: Detrimental effect on survival?Journal of Critical Care, 2009
- The significance of non-sustained hypotension in emergency department patients with sepsisIntensive Care Medicine, 2009
- Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008Intensive Care Medicine, 2007
- Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP) Study*Critical Care Medicine, 2006
- The Dopamine Paradox in Lung and Kidney EpitheliaAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Hemodynamic variables related to outcome in septic shockIntensive Care Medicine, 2005
- ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive SummaryCirculation, 2004
- Effect of norepinephrine on the outcome of septic shockCritical Care Medicine, 2000
- Practice parameters for hemodynamic support of sepsis in adult patients in sepsisCritical Care Medicine, 1999
- Anterior pituitary function during critical illness and dopamine treatmentCritical Care Medicine, 1996